Journal Article > CommentaryFull Text
Int J Tuberc Lung Dis. 30 June 2016; Volume 20 (Issue 9); DOI:10.5588/ijtld.16.0142
Suthar AB, Zachariah R, Harries AD
Int J Tuberc Lung Dis. 30 June 2016; Volume 20 (Issue 9); DOI:10.5588/ijtld.16.0142
The Sustainable Development Goals aim to end tuberculosis (TB) related deaths, transmission and catastrophic costs by 2030. Multisectorial action to accelerate socio-economic development, a new vaccine and novel diagnostics and medicines for treatment are key advances needed to end TB transmission. Achieving 90-90-90 targets for TB (i.e., 90% of vulnerable populations screened, 90% diagnosed and started on treatment, and at least 90% cured) will help accelerate progress towards reductions in mortality; however, passive case detection strategies, multidrug-resistant TB, human immunodeficiency virus coinfection and outdated pathways to care need to be overcome. Ending the catastrophic costs associated with TB will require expansion of health insurance coverage, comprehensive coverage of TB services, and limited indirect costs by vulnerable and poor populations.
Journal Article > ReviewFull Text
F1000Research. 15 September 2016; Volume 5; DOI:10.12688/f1000research.9247.1
Harries AD, Suthar AB, Takarinda KC, Tweya H, Kyaw NTT, et al.
F1000Research. 15 September 2016; Volume 5; DOI:10.12688/f1000research.9247.1
The international community has committed to ending the epidemics of HIV/AIDS, tuberculosis, malaria, and neglected tropical infections by 2030, and this bold stance deserves universal support. In this paper, we discuss whether this ambitious goal is achievable for HIV/AIDS and what is needed to further accelerate progress. The joint United Nations Program on HIV/AIDS (UNAIDS) 90-90-90 targets and the related strategy are built upon currently available health technologies that can diagnose HIV infection and suppress viral replication in all people with HIV. Nonetheless, there is much work to be done in ensuring equitable access to these HIV services for key populations and those who remain outside the rims of the traditional health services. Identifying a cure and a preventive vaccine would further help accelerate progress in ending the epidemic. Other disease control programmes could learn from the response to the HIV/AIDS epidemic.